Cue Biopharma, Inc. (FRA:1UC)
Germany · Delayed Price · Currency is EUR 0.5380
+0.0070 (1.32%)
At close: Nov 28, 2025
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of €42.78 million as of December 1, 2025. Its market cap has decreased by -55.65% in one year.
Market Cap
42.78M
Enterprise Value
30.49M
Revenue
6.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.54
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from 187.83M to 42.78M, a decrease of -77.22%. That is a compound annual growth rate of -17.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 42.78M | -35.86% |
| Dec 31, 2024 | 66.70M | -38.11% |
| Dec 29, 2023 | 107.77M | -6.11% |
| Dec 30, 2022 | 114.78M | -63.66% |
| Dec 31, 2021 | 315.86M | 2.00% |
| Dec 31, 2020 | 309.65M | -4.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |